We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.13B
AUM Growth
+$319M
Cap. Flow
+$340M
Cap. Flow %
30.14%
Top 10 Hldgs %
55.39%
Holding
5,820
New
1,131
Increased
1,662
Reduced
1,677
Closed
1,186

Sector Composition

Rank Sector Weight
1 Financials 2.49%
2 Industrials 2.24%
3 Healthcare 2.07%
4 Consumer Discretionary 2.05%
5 Energy 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JOE icon
951
St. Joe Company
JOE
$3.64B
$87K 0.01%
5,617
+2,517
+81% +$42.2K
MTB icon
952
M&T Bank
MTB
$36.2B
$87K 0.01%
700
+177
+34% +$21.8K
SBAC icon
953
SBA Communications
SBAC
$19B
$87K 0.01%
759
-2,138
-74% -$251K
VRTX icon
954
Vertex Pharmaceuticals
VRTX
$119B
$87K 0.01%
703
-6,073
-90% -$765K
FNHC
955
DELISTED
FedNat Holding Company Common Stock
FNHC
$87K 0.01%
3,612
+3,126
+643% +$84.9K
CUB
956
DELISTED
Cubic Corporation
CUB
$87K 0.01%
1,831
-232
-11% -$11.4K
ILG
957
DELISTED
ILG, Inc Common Stock
ILG
$87K 0.01%
3,810
+3,219
+545% +$81.4K
PMC
958
DELISTED
PharMerica Corporation
PMC
$87K 0.01%
2,600
-2,817
-52% -$86.5K
LPNT
959
DELISTED
LifePoint Health, Inc.
LPNT
$87K 0.01%
999
+650
+186% +$49.1K
ASRT
960
DELISTED
Assertio
ASRT
$86K 0.01%
67
+37
+123% +$50.7K
PDFS icon
961
PDF Solutions
PDFS
$2.01B
$86K 0.01%
5,379
+4,435
+470% +$76.3K
XLF icon
962
State Street Financial Select Sector SPDR ETF
XLF
$58B
$86K 0.01%
4,039
+2,154
+114% +$46.5K
VIVO
963
DELISTED
Meridian Bioscience Inc
VIVO
$86K 0.01%
4,624
+1,257
+37% +$23.3K
RTEC
964
DELISTED
Rudolph Technologies Inc
RTEC
$86K 0.01%
7,169
+3,715
+108% +$46.4K
IDTI
965
DELISTED
Integrated Device Technology I
IDTI
$86K 0.01%
+3,965
New +$85.5K
KERX
966
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$86K 0.01%
8,623
+1,701
+25% +$18.2K
CSG
967
DELISTED
CHAMBERS STR PPTYS COM
CSG
$86K 0.01%
10,858
+10,658
+5,329% +$82.9K
JRO
968
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$86K 0.01%
8,000
+7,680
+2,400% +$87.9K
DEG
969
DELISTED
ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS
DEG
$86K 0.01%
+4,185
New +$94.1K
CIVI
970
DELISTED
Civitas Resources
CIVI
$85K 0.01%
42
+7
+20% +$18.1K
FOR icon
971
Forestar Group
FOR
$1.47B
$85K 0.01%
6,487
+4,061
+167% +$58.6K
GDOT icon
972
Green Dot
GDOT
$754M
$85K 0.01%
4,480
+1,198
+37% +$19.4K
HOPE icon
973
Hope Bancorp
HOPE
$1.81B
$85K 0.01%
5,782
-3,409
-37% -$49.9K
RBC icon
974
RBC Bearings
RBC
$18.1B
$85K 0.01%
1,186
-1,457
-55% -$107K
TPST icon
975
Tempest Therapeutics
TPST
$14M
$85K 0.01%
1
-1
-50% -$91.6K

Similar funds

Tower Research Capital (TRC)'s Q2 2015 Portfolio in Review

As of Q2 2015, Tower Research Capital (TRC) held 5,820 positions worth $1.13B, up 39% from $809M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC) deployed $340M of net new capital in Q2 2015, opening 1,131 new positions and adding to 1,662 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.

By sector, the portfolio is most concentrated in Financials at 2.5% of assets, down from 4.6% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $42.4M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2015 buy was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $337M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2015 reduction was Invesco QQQ Trust, cutting an estimated $42.4M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q2 2015, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.13B portfolio in Q2 2015.
  • Tower Research Capital (TRC) opened 1,131 new positions and closed 1,186 in Q2 2015.
  • Tower Research Capital (TRC)'s portfolio value rose 39% quarter-over-quarter to $1.13B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2015, filed 30 Jul 2015.